- 专利标题： METHOD OF TREATING PULMONARY FIBROSIS BY TARGETING GLYCOGEN UTILIZATION
-
申请号： US18583392申请日： 2024-02-21
-
公开(公告)号： US20240325326A1公开(公告)日： 2024-10-03
- 发明人: Matthew S. Gentry , Ramon C. Sun , Ronald C Bruntz , Christopher M Waters
- 申请人： University of Kentucky Research Foundation
- 申请人地址： US KY Lexington
- 专利权人： University of Kentucky Research Foundation
- 当前专利权人： University of Kentucky Research Foundation
- 当前专利权人地址： US KY Lexington
- 主分类号： A61K31/167
- IPC分类号： A61K31/167 ; A61K31/166 ; A61K31/404 ; A61K31/4155 ; A61K31/4178 ; A61K31/4184 ; A61K31/426 ; A61K31/428 ; A61K31/433 ; A61K31/436 ; A61K31/47 ; A61K31/5375 ; A61P11/00
摘要：
A method for treating pulmonary fibrosis (PF) is provided. The method includes administering to a subject in need thereof an effective amount of a compound selected from the group consisting of a glycogen phosphatase inhibitor, an acid alpha-glucosidase (GAA) inhibitor, a glycogen synthase (GYS) inhibitor, a glycogen phosphorylase (GP) inhibitor, and combinations thereof, or a pharmaceutically acceptable salt thereof.
信息查询
